Literature DB >> 30603282

Glycemic targets for elderly patients with diabetes.

Masakazu Haneda1, Hideki Ito2.   

Abstract

Entities:  

Keywords:  Diabetes mellitus; Elderly; Glycemic targets

Year:  2016        PMID： 30603282      PMCID： PMC6224973          DOI： 10.1007/s13340-016-0293-8

Source DB:  PubMed          Journal:  Diabetol Int        ISSN： 2190-1678


× No keyword cloud information.
  7 in total

1.  Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial--study design, baseline characteristics and effects of intervention.

Authors:  Atsushi Araki; Satoshi Iimuro; Takashi Sakurai; Hiroyuki Umegaki; Katsuya Iijima; Hiroshi Nakano; Kenzo Oba; Koichi Yokono; Hirohito Sone; Nobuhiro Yamada; Junya Ako; Koichi Kozaki; Hisayuki Miura; Atsunori Kashiwagi; Ryuichi Kikkawa; Yukio Yoshimura; Tadasumi Nakano; Yasuo Ohashi; Hideki Ito
Journal:  Geriatr Gerontol Int       Date:  2012-04       Impact factor: 2.730

2.  National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations.

Authors:  Andrew I Geller; Nadine Shehab; Maribeth C Lovegrove; Scott R Kegler; Kelly N Weidenbach; Gina J Ryan; Daniel S Budnitz
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

Review 3.  Screening Tool for Older Persons' Appropriate Prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on "Guidelines for medical treatment and its safety in the elderly".

Authors:  Taro Kojima; Katsuyoshi Mizukami; Naoki Tomita; Hiroyuki Arai; Takashi Ohrui; Masato Eto; Yasushi Takeya; Yoshitaka Isaka; Hiromi Rakugi; Noriko Sudo; Hidenori Arai; Hiroaki Aoki; Shigeo Horie; Shinya Ishii; Koh Iwasaki; Shin Takayama; Yusuke Suzuki; Toshifumi Matsui; Fumihiro Mizokami; Katsunori Furuta; Kenji Toba; Masahiro Akishita
Journal:  Geriatr Gerontol Int       Date:  2016-09       Impact factor: 2.730

Review 4.  Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis.

Authors:  Atsushi Goto; Onyebuchi A Arah; Maki Goto; Yasuo Terauchi; Mitsuhiko Noda
Journal:  BMJ       Date:  2013-07-29

5.  Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study.

Authors:  Elbert S Huang; Neda Laiteerapong; Jennifer Y Liu; Priya M John; Howard H Moffet; Andrew J Karter
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

6.  Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.

Authors:  Rachel A Whitmer; Andrew J Karter; Kristine Yaffe; Charles P Quesenberry; Joseph V Selby
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

7.  Diabetes in older adults.

Authors:  M Sue Kirkman; Vanessa Jones Briscoe; Nathaniel Clark; Hermes Florez; Linda B Haas; Jeffrey B Halter; Elbert S Huang; Mary T Korytkowski; Medha N Munshi; Peggy Soule Odegard; Richard E Pratley; Carrie S Swift
Journal:  Diabetes Care       Date:  2012-10-25       Impact factor: 19.112
  7 in total
  10 in total

1.  Eighteen-year trends in the management of patients with diabetes in the Shiga Diabetes Clinical Survey: overall trends and differences by age group.

Authors:  Itsuko Miyazawa; Hiroshi Maegawa; Aya Kadota; Takashi Nakamura; Makoto Konishi; Shinichi Ochi; Katsuyuki Miura; Motozumi Okamoto
Journal:  Diabetol Int       Date:  2022-02-17

2.  Hypoglycemic coma in an elderly adult switched from twice-daily vildagliptin to once-daily glimepiride to improve drug adherence.

Authors:  Shunsuke Tominari; Megumi Yasuda; Takehiro Kato; Mayu Sakai; Sodai Kubota; Kenta Nonomura; Tokuyuki Hirose; Ken Takao; Yanyan Liu; Masami Mizuno; Takuo Hirota; Katsumi Iizuka; Tetsuya Suwa; Yukio Horikawa; Daisuke Yabe
Journal:  Diabetol Int       Date:  2021-05-05

3.  Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management.

Authors:  Keiko Arai; Tetsuo Nishikawa; Shohei Yuasa; Shin-Ichiro Shirabe; Yoko Matsuzawa; Shigeyuki Ohtsu; Koich Hirao; Hisao Mori
Journal:  Diabetes Ther       Date:  2020-05-22       Impact factor: 2.945

4.  Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study.

Authors:  Naoto Katakami; Tomoya Mita; Mitsuyoshi Takahara; Toshitaka Yajima; Fumitaka Wada; Masaru Kawashima; Iichiro Shimomura; Hirotaka Watada
Journal:  Diabetes Ther       Date:  2020-06-05       Impact factor: 2.945

5.  Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial.

Authors:  Mark E Cooper; Julio Rosenstock; Takashi Kadowaki; Yutaka Seino; Christoph Wanner; Sven Schnaidt; Douglas Clark; Odd Erik Johansen
Journal:  Diabetes Obes Metab       Date:  2020-02-27       Impact factor: 6.577

6.  Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.

Authors:  Mark A Espeland; Richard E Pratley; Julio Rosenstock; Takashi Kadowaki; Yutaka Seino; Bernard Zinman; Nikolaus Marx; Darren K McGuire; Knut Robert Andersen; Michaela Mattheus; Annett Keller; Maria Weber; Odd Erik Johansen
Journal:  Diabetes Obes Metab       Date:  2020-12-06       Impact factor: 6.577

7.  Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan.

Authors:  Wataru Ogawa; Yushi Hirota; Takeshi Osonoi; Takahiro Tosaki; Yoshiro Kato; Kazunori Utsunomiya; Rimei Nishimura; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2020-09-09       Impact factor: 4.232

8.  Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium-glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes.

Authors:  Daisuke Yabe; Kosuke Shiki; Keiko Suzaki; Thomas Meinicke; Yutaro Kotobuki; Kenichiro Nishida; Douglas Clark; Atsutaka Yasui; Yutaka Seino
Journal:  BMJ Open       Date:  2021-04-07       Impact factor: 2.692

Review 9.  Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus.

Authors:  Jin Yu; Seung-Hwan Lee; Mee Kyoung Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28

10.  Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).

Authors:  Hiroki Yokoyama; Shin-Ichi Araki; Katsuya Yamazaki; Koichi Kawai; Shin-Ichiro Shirabe; Mariko Oishi; Azuma Kanatsuka; Noriharu Yagi; Daijiro Kabata; Ayumi Shintani; Hiroshi Maegawa
Journal:  BMJ Open Diabetes Res Care       Date:  2022-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.